Search research articles
Contact Us
Filters
Showing results (631-640 of 662) with videos related to
Page
of 67
Sort By:
Blood
|
December 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage
Umeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, et al.
Allergy
|
February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Jakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
Cancer Research
|
July 3, 2021
<i>TET2</i> and <i>DNMT3A</i> Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors
Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, et al.
BMC Cancer
|
September 24, 2022
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes
Tamara K Moyo, Jason H Mendler, Raphael Itzykson, et al.
The Lancet. Haematology
|
January 29, 2021
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study
Lisa Pleyer, Michael Leisch, Alexandra Kourakli, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 20, 2022
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis
Johannes Lübke, Juliana Schwaab, Deborah Christen, et al.
The Journal of Allergy and Clinical Immunology
|
October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Karin Hartmann, Luis Escribano, Clive Grattan, et al.
Leukemia
|
November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
Hanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
Hemasphere
|
December 13, 2021
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent, Cem Akin, Karin Hartmann, et al.
Leukemia
|
January 15, 2025
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis
Axel Rüfer, Henning Nilius, Olivier Hermine, et al.
Page
of 67
Search research articles
Search
Showing results (631-640 of 662) with videos related to
Sort By:
Page
of 67
Blood
|
December 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage
Umeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, et al.
Allergy
|
February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Jakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
Cancer Research
|
July 3, 2021
<i>TET2</i> and <i>DNMT3A</i> Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors
Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, et al.
BMC Cancer
|
September 24, 2022
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes
Tamara K Moyo, Jason H Mendler, Raphael Itzykson, et al.
The Lancet. Haematology
|
January 29, 2021
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study
Lisa Pleyer, Michael Leisch, Alexandra Kourakli, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 20, 2022
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis
Johannes Lübke, Juliana Schwaab, Deborah Christen, et al.
The Journal of Allergy and Clinical Immunology
|
October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Karin Hartmann, Luis Escribano, Clive Grattan, et al.
Leukemia
|
November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
Hanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
Hemasphere
|
December 13, 2021
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent, Cem Akin, Karin Hartmann, et al.
Leukemia
|
January 15, 2025
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis
Axel Rüfer, Henning Nilius, Olivier Hermine, et al.
Page
of 67